date: 17/06/2020
Reaction of Xavier De Cuyper, CEO of the FAMHP:
“I have complete confidence in my teams. Criticisms reported by the press are being investigated and full transparency will be given as to how the tests have been validated and placed on the market. If an error has been made, the necessary actions will be taken. I can guarantee that, since the beginning of the COVID-19 crisis, all FAMHP teams have been working tirelessly, under intense and difficult circumstances, with the sole aim of guaranteeing the best care for patients in Belgium. “